Edwards Lifesciences Corp
EW
53 insider filings · Latest: Aug 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | May 18 9:28 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Sale | 17,968 | $81.96 | $1.5M | 30,969.576(I) | View → |
| May 18, 2026 | May 18 8:10 PM | Lippis Daniel J. | Proposed Sale | 1,858 | $81.14 | $150.8K | — | View → |
| May 15, 2026 | May 15 8:04 PM | BOBO DONALD E JR | Proposed Sale | 9,968 | $82.07 | $818.1K | — | View → |
| May 12, 2026 | May 12 8:55 PM | Bernard J ZovighianDirector, CEO | Sale | 36,351 | $77.93 | $2.8M | 12,039.551(I) | View → |
| May 12, 2026 | May 12 8:02 PM | Zovighian Bernard J | Proposed Sale | 36,874 | $77.93 | $2.9M | — | View → |
| May 11, 2026 | May 12 1:33 AM | Wayne MarkowitzCVP, JAPAC | Sale | 593 | $79.73 | $47.3K | 21,679.871(D) | View → |
| May 11, 2026 | May 11 8:10 PM | Markowitz Wayne | Proposed Sale | 593 | $79.73 | $47.3K | — | View → |
| May 4, 2026 | May 4 11:30 PM | Daniel J. LippisCVP, TAVR | Sale | 1,019 | $83.98 | $85.6K | 33,681.91(D) | View → |
| May 1, 2026 | May 4 11:30 PM | Daniel J. LippisCVP, TAVR | Sale | 1,019 | $83.01 | $84.6K | 33,933.91(D) | View → |
| May 4, 2026 | May 4 8:32 PM | Lippis Daniel J. | Proposed Sale | 1,019 | $83.98 | $85.6K | — | View → |
| Apr 9, 2026 | Apr 9 11:34 PM | Scott B. UllemCVP, Chief Financial Officer | Sale | 13,000 | $80.04 | $1.0M | 39,699(D) | View → |
| Apr 6, 2026 | Apr 7 12:42 AM | Daniel J. LippisCVP, TAVR | Sale | 1,019 | $80.98 | $82.5K | 33,933.91(D) | View → |
| Apr 2, 2026 | Apr 2 9:13 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Sale | 22,680 | $80.16 | $1.8M | 21,266.253(D) | View → |
| Mar 11, 2026 | Mar 11 9:15 PM | Scott B. UllemCVP, Chief Financial Officer | Sale | 13,000 | $84.92 | $1.1M | 39,699(D) | View → |
| Mar 11, 2026 | Mar 11 9:10 PM | Daniel J. LippisCVP, TAVR | Sale | 1,019 | $85.38 | $87.0K | 33,933.91(D) | View → |
| Mar 11, 2026 | Mar 11 8:05 PM | Lippis Daniel J. | Proposed Sale | 3,057 | $85.38 | $261.0K | — | View → |
| Mar 11, 2026 | Mar 11 8:02 PM | Ullem Scott B. | Proposed Sale | 26,000 | $84.92 | $2.2M | — | View → |
| Mar 2, 2026 | Mar 2 10:50 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Sale | 11,340 | $85.93 | $974.4K | 21,266.253(D) | View → |
| Feb 25, 2026 | Feb 27 12:33 AM | Donald E Bobo JRCVP,Strategy/Corp Development | Sale | 24,000 | $83.84 | $2.0M | 21,266.253(D) | View → |
| Feb 25, 2026 | Feb 26 9:08 PM | DONALD E BOBO JR. | Proposed Sale | 24,000 | $83.84 | $2.0M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | Apr 9 11:34 PM | Scott B. UllemCVP, Chief Financial Officer | Option Exercise | 13,000 | $59.26 | 13,000(D) | View → |
| Apr 6, 2026 | Apr 7 12:42 AM | Daniel J. LippisCVP, TAVR | Option Exercise | 1,019 | $59.26 | 2,038(D) | View → |
| Apr 2, 2026 | Apr 2 9:13 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Option Exercise | 22,680 | $59.26 | 0(D) | View → |
| Mar 11, 2026 | Mar 11 9:15 PM | Scott B. UllemCVP, Chief Financial Officer | Option Exercise | 13,000 | $59.26 | 26,000(D) | View → |
| Mar 11, 2026 | Mar 11 9:10 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 1,019 | $59.26 | 3,057(D) | View → |
| Mar 2, 2026 | Mar 2 10:50 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Option Exercise | 11,340 | $59.26 | 22,680(D) | View → |
| Feb 12, 2026 | Feb 13 10:37 PM | Bernard J ZovighianDirector, CEO | Option Exercise | 25,350 | $59.26 | 0(D) | View → |
← Previous
Page 2 of 2